Matheus Freitas Cardoso de Azevedo

Efficacy and Safety of Ustekinumab in Patients With Crohn`s disease: Data From a Real World Study in Brazil

BACKGROUND: Ustekinumab (UST)is a fully human monoclonal antibody against IL-12/23 approved in Brazil for the treatment of moderate-to-severe Crohn’s disease (CD) in November 2017. U...

Erika Ruback Bertges ;

Julio Fonseca Chebli ;

Liliana Andrade Chebli ;

Marley Ribeiro Feitosa ;

Rogerio Serafim Parra ;

Omar Féres ;

Natália Queiroz ;

Antonio Jose Alves Jr.;

Tárcia Gomes ;

Orlando Ambrogini Jr.;

José Joaquim Ribeiro da Rocha ;

Bianca Schiavetti ;

Marcio Lubini ;

Matheus Freitas Cardoso de Azevedo ;

12/13/2019

Inflammatory Bowel Diseases and Autoimmune Hepatitis: Is Anti-TNF Therapy an Option?

BACKGROUND: Comorbidities among immune mediated inflammatory disorders are frequently reported (1). Although some physicians are not aware of the potential association between autoimmune ...

Matheus Freitas Cardoso de Azevedo ;

Luisa Leite Barros ;

Carlos Alexandre ;

Adérson Omar Mourao Cintra Damião ;

Eduardo Cançado ;

André Leite ;

Luciane Milani ;

Debora Terrabuio ;

Jane Oba ;

Beatriz Rocha ;

Aytan Sipahi ;

Natália Queiroz ;

12/12/2019

Ophthalmic Complications in Patients With Inflammatory Bowel Disease During Anti-TNF Treatment

BACKGROUND: The main ophthalmologic extraintestinal manifestations (EIM) in inflammatory bowel disease (IBD) patients are episcleritis, uveitis and scleritis. Uncommon ophtalmic involveme...

Jane Oba ;

Natália Queiroz ;

Beatriz Rocha ;

Aytan Sipahi ;

Carlos Sobrado ;

Alexandre Carlos ;

Matheus Freitas Cardoso de Azevedo ;

Aline Goncalves ;

Luciane Milani ;

Luisa Leite Barros ;

Adérson Omar Mourao Cintra Damião ;

André Leite ;

12/12/2019

Fatal Presentation of Thrombotic Cutaneous Gangrene Associated With Acute Severe Colitis

Clinics Hospital, University of São Paulo School of Medicine, São Paulo, Brazil.

Carlos Alexandre de Souza ;

Rita De Cassia Parente Prado ;

Luisa Leite Barros ;

Lucas Fortes Portela Ferreira ;

Adérson Omar Mourao Cintra Damião ;

Jane Oba ;

Matheus Freitas Cardoso de Azevedo ;

01/11/2024

Xpert MTB/RIF Test in Differential Diagnosis of Intestinal Tuberculosis and Crohn’s Disease

1 General Hospital Roberto Santos, São Paulo, Brazil; 2 Bahia State University UNEB, Salvador, Brazil.

Matheus Freitas Cardoso de Azevedo ;

Fernanda Rodrigues ;

Luciana Araujo ;

Adriana Ribas Andrade ;

01/11/2024

Anti-TNF Therapy in Elderly Patients With Inflammatory Bowel Disease in a Tuberculosis-Endemic Country

1 Clinics Hospital, University of São Paulo School of Medicine, São Paulo, Brazil; 2 Clinics Hospital, São Paulo, Brazil.

Matheus Freitas Cardoso de Azevedo ;

Carlos Alexandre de Souza ;

Paula De Azevedo Lopes ;

Andre Okuhara Fujita ;

Daniela Sanches Brito ;

Daniela Midori Kamada ;

Rita De Cassia Parente Prado ;

Julia Carvalho De Andrade ;

Luisa Leite Barros ;

Adérson Omar Mourao Cintra Damião ;

Jane Oba ;

01/11/2024

Efficacy and Safety of Ustekinumab in Patients With Crohn`s disease: Data From a Real World Study in Brazil

BACKGROUND: Ustekinumab (UST)is a fully human monoclonal antibody against IL-12/23 approved in Brazil for the treatment of moderate-to-severe Crohn’s disease (CD) in November 2017. UST ha...

Antonio Jose Alves Jr.;

Rogerio Serafim Parra ;

Orlando Ambrogini Jr.;

Natália Queiroz ;

Bianca Schiavetti ;

Marcio Lubini ;

Erika Ruback Bertges ;

Julio Fonseca Chebli ;

Liliana Andrade Chebli ;

Marley Ribeiro Feitosa ;

Matheus Freitas Cardoso de Azevedo ;

Omar Féres ;